AN2 Therapeutics (ANTX) Cash & Current Investments (2021 - 2026)
AN2 Therapeutics (ANTX) reported Cash & Current Investments of $78.39 million for Q2 2026, up 24.6% from $62.92 million a year earlier but down 8.1% from the prior quarter.
Powered by 
Analysis
AN2 Therapeutics (ANTX) Cash & Current Investments (2021 - 2026) Analysis & Trends
At the end of FY2025, AN2 Therapeutics posted Cash & Current Investments of $58 million, down 30.7% from FY2024.
- Cash & Current Investments has a four-year compound annual growth rate of -0.2% (FY2021 to FY2025).
- By year, Cash & Current Investments came in at $83.67 million in FY2024 (-22.0%), $107.3 million in FY2023 (+11.7%), $96.06 million in FY2022 (+64.0%) and $58.56 million in FY2021.
- Five-year quarterly Cash & Current Investments spans a low of $58 million in Q4 2025 and a high of $123.82 million in Q3 2023.
- Year over year, Cash & Current Investments gained in two of the last eight quarters, with an average decline of 17.5%.
- The high point for year-over-year Cash & Current Investments in five years was Q4 2022 (growth of 64.0%); the low point was Q1 2025 (a decline of 41.3%).
- Per Business Quant data, the three quarters before Q2 2026 came in at $85.3 million (Q1 2026), $58 million (Q4 2025) and $61.92 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Current Investments (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,199.50 Bn | 1,168.08 Bn | 19.71 Bn | 8.95 Bn |
| 2 | Johnson & Johnson | 635.17 Bn | 555.03 Bn | 17.30 Bn | 17.23 Bn |
| 3 | AbbVie | 504.69 Bn | 477.85 Bn | 12.70 Bn | 6.57 Bn |
| 4 | Merck | 358.43 Bn | 312.86 Bn | 12.21 Bn | 7.14 Bn |
| 5 | Novartis Ag | 288.36 Bn | 252.75 Bn | 11.24 Bn | 7.69 Bn |
| 6 | Astrazeneca | 265.78 Bn | 239.54 Bn | 12.86 Bn | 4.90 Bn |
| 7 | Amgen | 237.46 Bn | 192.86 Bn | 7.24 Bn | 13.99 Bn |
| 8 | Gilead Sciences | 193.65 Bn | 167.76 Bn | 6.22 Bn | 3.18 Bn |
| 9 | Pfizer | 171.05 Bn | 118.00 Bn | 10.94 Bn | 11.70 Bn |
| 10 | AN2 Therapeutics | 128.90 Mn | -154.71 Mn | - | 78.39 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 78.39 Mn |
| Mar 31, 2026 | 85.30 Mn |
| Dec 31, 2025 | 58.00 Mn |
| Sep 30, 2025 | 61.92 Mn |
| Jun 30, 2025 | 62.92 Mn |
| Mar 31, 2025 | 67.08 Mn |
| Dec 31, 2024 | 83.67 Mn |
| Sep 30, 2024 | 93.43 Mn |
| Jun 30, 2024 | 104.57 Mn |
| Mar 31, 2024 | 114.22 Mn |
| Dec 31, 2023 | 107.30 Mn |
| Sep 30, 2023 | 123.82 Mn |
| Jun 30, 2023 | 95.26 Mn |
| Mar 31, 2023 | 88.52 Mn |
| Dec 31, 2022 | 96.06 Mn |
| Sep 30, 2022 | 104.38 Mn |
| Jun 30, 2022 | 113.39 Mn |
| Mar 31, 2022 | 118.35 Mn |
| Dec 31, 2021 | 58.56 Mn |
API Access
AN2 Therapeutics Cash & Current Investments API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=cash-and-current-investments&ticker=ANTX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "cash-and-current-investments", "ticker": "ANTX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=cash-and-current-investments&ticker=ANTX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();